These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 38352041)
1. Lithium: effects in animal models of vanishing white matter are not promising. Witkamp D; Oudejans E; Hoogterp L; Hu-A-Ng GV; Glaittli KA; Stevenson TJ; Huijsmans M; Abbink TEM; van der Knaap MS; Bonkowsky JL Front Neurosci; 2024; 18():1275744. PubMed ID: 38352041 [TBL] [Abstract][Full Text] [Related]
2. Vanishing white matter. van der Knaap MS; Bugiani M; Abbink TEM Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396 [TBL] [Abstract][Full Text] [Related]
3. Vanishing white matter: deregulated integrated stress response as therapy target. Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619 [TBL] [Abstract][Full Text] [Related]
4. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver. Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691 [No Abstract] [Full Text] [Related]
5. Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1. Witkamp D; Oudejans E; Hu-A-Ng GV; Hoogterp L; Krzywańska AM; Žnidaršič M; Marinus K; de Veij Mestdagh CF; Bartelink I; Bugiani M; van der Knaap MS; Abbink TEM Ann Clin Transl Neurol; 2022 Aug; 9(8):1147-1162. PubMed ID: 35778832 [TBL] [Abstract][Full Text] [Related]
6. Pridopidine subtly ameliorates motor skills in a mouse model for vanishing white matter. Oudejans E; Witkamp D; Hu-A-Ng GV; Hoogterp L; van Rooijen-van Leeuwen G; Kruijff I; Schonewille P; Lalaoui El Mouttalibi Z; Bartelink I; van der Knaap MS; Abbink TE Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38171595 [TBL] [Abstract][Full Text] [Related]
7. Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions. Wisse LE; Penning R; Zaal EA; van Berkel CGM; Ter Braak TJ; Polder E; Kenney JW; Proud CG; Berkers CR; Altelaar MAF; Speijer D; van der Knaap MS; Abbink TEM Front Cell Neurosci; 2017; 11():411. PubMed ID: 29375313 [TBL] [Abstract][Full Text] [Related]
9. Adult mouse eIF2Bε Arg191His astrocytes display a normal integrated stress response in vitro. Wisse LE; Ter Braak TJ; van de Beek MC; van Berkel CGM; Wortel J; Heine VM; Proud CG; van der Knaap MS; Abbink TEM Sci Rep; 2018 Feb; 8(1):3773. PubMed ID: 29491431 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells. Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215 [TBL] [Abstract][Full Text] [Related]
11. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model. Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290 [TBL] [Abstract][Full Text] [Related]
12. Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy. Atzmon A; Herrero M; Sharet-Eshed R; Gilad Y; Senderowitz H; Elroy-Stein O Front Mol Neurosci; 2018; 11():336. PubMed ID: 30279648 [TBL] [Abstract][Full Text] [Related]
13. Proteomic dissection of vanishing white matter pathogenesis. Man JHK; Zarekiani P; Mosen P; de Kok M; Debets DO; Breur M; Altelaar M; van der Knaap MS; Bugiani M Cell Mol Life Sci; 2024 May; 81(1):234. PubMed ID: 38789799 [TBL] [Abstract][Full Text] [Related]
15. Hillen AEJ; Hruzova M; Rothgangl T; Breur M; Bugiani M; van der Knaap MS; Schwank G; Heine VM Mol Ther Methods Clin Dev; 2022 Jun; 25():17-25. PubMed ID: 35317047 [TBL] [Abstract][Full Text] [Related]
16. eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Wong YL; LeBon L; Basso AM; Kohlhaas KL; Nikkel AL; Robb HM; Donnelly-Roberts DL; Prakash J; Swensen AM; Rubinstein ND; Krishnan S; McAllister FE; Haste NV; O'Brien JJ; Roy M; Ireland A; Frost JM; Shi L; Riedmaier S; Martin K; Dart MJ; Sidrauski C Elife; 2019 Jan; 8():. PubMed ID: 30624206 [TBL] [Abstract][Full Text] [Related]
17. eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes. Herrero M; Mandelboum S; Elroy-Stein O Neuromolecular Med; 2019 Sep; 21(3):303-313. PubMed ID: 31134486 [TBL] [Abstract][Full Text] [Related]
18. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease. Cabilly Y; Barbi M; Geva M; Marom L; Chetrit D; Ehrlich M; Elroy-Stein O PLoS One; 2012; 7(10):e46715. PubMed ID: 23056417 [TBL] [Abstract][Full Text] [Related]
19. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease. Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143 [TBL] [Abstract][Full Text] [Related]